Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

 v2.3.0.11
Consolidated Statements of Cash Flows (USD $)
In Thousands
12 Months Ended
Apr. 30, 2011
Apr. 30, 2010
Apr. 30, 2009
Cash flows from operating activities:      
Net income (loss) $ 58,874 $ 5,298 $ (10,092)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 12,671 11,493 11,583
Stock-based compensation expense 15,547 17,729 16,301
Impairment of intangible assets 880    
Loss on disposition of property and equipment 80 323 3,740
Provision for doubtful accounts 7,650 3,340 9,127
(Gain) loss on cash surrender value of life insurance policies (6,246) (9,558) 3,578
Gain on marketable securities classified as trading (7,599) (11,137)  
Change in fair value of acquisition-related contingent consideration (4,919)    
Realized loss on available-for-sale marketable securities     5,040
Other-than-temporary impairment on available-for-sale securities, net of unrealized gains reclassified to other income upon the transfer of available-for-sale securities to trading     9,967
Deferred income taxes 5,954 (20,862) (4,354)
Change in other assets and liabilities:      
Deferred compensation 11,716 15,828 (3,085)
Receivables (28,140) (33,516) 44,639
Prepaid expenses (6,496) (4,198) (1,340)
Investment in unconsolidated subsidiaries (1,862) (91) (2,365)
Income taxes payable (1,686) 2,844 (18,909)
Accounts payable and accrued liabilities 40,109 (783) (82,236)
Other (899) (7,556) 21,577
Net cash provided by (used in) operating activities 95,634 (30,846) 3,171
Cash flows from investing activities:      
Purchase of property and equipment (27,889) (7,282) (11,947)
Purchase of intangible assets   (3,481)  
Purchase of marketable securities (65,964) (4,163) (23,449)
Proceeds from sales/maturities of marketable securities 28,618 13,374 19,345
Change in restricted cash (10,007)    
Cash paid for acquisitions, net of cash acquired and contingent consideration   (18,734) (12,900)
Payment of contingent consideration from acquisitions (5,795) (2,405)  
Premiums on life insurance policies (1,702) (1,711) (1,781)
Dividends received from unconsolidated subsidiaries 1,608 958 2,952
Net cash used in investing activities (81,131) (23,444) (27,780)
Cash flows from financing activities:      
Payments on life insurance policy loans   (183) (770)
Borrowings under life insurance policies 6,039 5,500 1,721
Purchase of common stock (13,844) (3,136) (9,588)
Proceeds from exercise of warrants 2,983    
Proceeds from issuance of common stock upon exercise of employee stock options and in connection with an employee stock purchase plan 10,084 6,526 3,609
Tax benefit (expense) from exercise of stock options 1,287 (611) (654)
Payment of dividends by majority owned consolidated subsidiaries (600)    
Net cash provided by (used in) financing activities 5,949 8,096 (5,682)
Effect of exchange rate changes on cash and cash equivalents 7,171 10,427 (20,005)
Net Increase (decrease) in cash and cash equivalents 27,623 (35,767) (50,296)
Cash and cash equivalents at beginning of year 219,233 255,000 305,296
Cash and cash equivalents at end of year 246,856 219,233 255,000
Supplemental cash flow information:      
Cash used to pay interest 4,834 3,992 5,969
Cash used to pay income taxes $ 25,329 $ 8,111 $ 24,369